{"id":37935,"date":"2025-07-25T13:03:02","date_gmt":"2025-07-25T05:03:02","guid":{"rendered":"https:\/\/flcube.com\/?p=37935"},"modified":"2025-07-25T13:03:03","modified_gmt":"2025-07-25T05:03:03","slug":"roche-ag-reports-7-sales-growth-in-h1-2025-driven-by-pharmaceuticals-expansion","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=37935","title":{"rendered":"Roche AG Reports 7% Sales Growth in H1 2025, Driven by Pharmaceuticals Expansion"},"content":{"rendered":"\n<p>Swiss giant Roche AG (<a href=\"https:\/\/www.google.com\/finance\/quote\/ROG:SWX\">SWX: ROG<\/a>, <a href=\"https:\/\/www.google.com\/finance\/quote\/RHHBY:OTCMKTS\">OTCMKTS: RHHBY<\/a>) announced its H1 2025 financial results, reporting a 7% year-on-year (YOY) increase in global group sales to CHF 30.94 billion (USD 39 billion) in constant exchange rate terms. The Pharmaceuticals division drove this growth with a 10% expansion to CHF 23.99 billion (USD 30.24 billion), while the Diagnostics division reported flat growth at CHF 6.96 billion (USD 8.77 billion).<\/p>\n\n\n\n<p><strong>Pharmaceuticals Division Growth Drivers<\/strong><br>CEO Thomas Schinecker highlighted the strong growth momentum driven by pharmaceuticals. The top five growth drivers were:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Phesgo (pertuzumab\/trastuzumab\/hyaluronidase)<\/li>\n\n\n\n<li>Vabysmo (faricimab)<\/li>\n\n\n\n<li>Xolair (omalizumab)<\/li>\n\n\n\n<li>Hemlibra (emicizumab)<\/li>\n\n\n\n<li>Ocrevus (ocrelizumab)<\/li>\n<\/ol>\n\n\n\n<p>These contributed CHF 10.6 billion (USD 13.4 billion) in sales during the six-month period, an increase of CHF 1.7 billion (USD 2.1 billion) from H1 2024.<\/p>\n\n\n\n<p><strong>Geographic Performance<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>United States<\/strong>: CHF 12,670 million (52.8% of sales), +10%<\/li>\n\n\n\n<li><strong>Europe<\/strong>: CHF 4,566 million (19.0% of sales), +5%<\/li>\n\n\n\n<li><strong>Japan<\/strong>: CHF 1,425 million (5.9% of sales), +5%<\/li>\n\n\n\n<li><strong>International<\/strong>: CHF 5,324 million (22.3% of sales), +14%<\/li>\n<\/ul>\n\n\n\n<p>China market sales rose by 9%, driven by the uptake of Phesgo, strong sales of Xofluza (baloxavir marboxil), and the roll-out of Polivy (polatuzumab vedotin) and Vabysmo.<\/p>\n\n\n\n<p><strong>Diagnostics Division Performance<\/strong><br>The Diagnostics division&#8217;s flat performance was attributed to &#8220;the impact of healthcare pricing reforms in China.&#8221; This led to a -15% decline in Asia-Pacific sales, offset by a 5% increase in the Europe, Middle East, and Africa (EMEA) region, 6% growth in North America, and 14% expansion in Latin America.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/irp250724.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of irp250724.\"><\/object><a id=\"wp-block-file--media-2ece6512-01b3-4bc0-b5d1-d8d4c2651a68\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/irp250724.pdf\">irp250724<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/irp250724.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-2ece6512-01b3-4bc0-b5d1-d8d4c2651a68\">Download<\/a><\/div>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/hy25e.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of hy25e.\"><\/object><a id=\"wp-block-file--media-54a9b824-6fb2-4316-8064-b8aa626435b5\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/hy25e.pdf\">hy25e<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/hy25e.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-54a9b824-6fb2-4316-8064-b8aa626435b5\">Download<\/a><\/div>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/irp250724-a.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of irp250724-a.\"><\/object><a id=\"wp-block-file--media-3031b211-b5cf-4215-b87c-1874b77235f2\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/irp250724-a.pdf\">irp250724-a<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/irp250724-a.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-3031b211-b5cf-4215-b87c-1874b77235f2\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Swiss giant Roche AG (SWX: ROG, OTCMKTS: RHHBY) announced its H1 2025 financial results, reporting&#8230;<\/p>\n","protected":false},"author":1,"featured_media":37936,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[27,940,163,939],"class_list":["post-37935","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","tag-finanical-reports","tag-otcmkts-rhhby","tag-roche","tag-swx-rog"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Roche AG Reports 7% Sales Growth in H1 2025, Driven by Pharmaceuticals Expansion - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Swiss giant Roche AG (SWX: ROG, OTCMKTS: RHHBY) announced its H1 2025 financial results, reporting a 7% year-on-year (YOY) increase in global group sales to CHF 30.94 billion (USD 39 billion) in constant exchange rate terms. The Pharmaceuticals division drove this growth with a 10% expansion to CHF 23.99 billion (USD 30.24 billion), while the Diagnostics division reported flat growth at CHF 6.96 billion (USD 8.77 billion).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=37935\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Roche AG Reports 7% Sales Growth in H1 2025, Driven by Pharmaceuticals Expansion\" \/>\n<meta property=\"og:description\" content=\"Swiss giant Roche AG (SWX: ROG, OTCMKTS: RHHBY) announced its H1 2025 financial results, reporting a 7% year-on-year (YOY) increase in global group sales to CHF 30.94 billion (USD 39 billion) in constant exchange rate terms. The Pharmaceuticals division drove this growth with a 10% expansion to CHF 23.99 billion (USD 30.24 billion), while the Diagnostics division reported flat growth at CHF 6.96 billion (USD 8.77 billion).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=37935\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-25T05:03:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-25T05:03:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2506.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37935#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37935\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Roche AG Reports 7% Sales Growth in H1 2025, Driven by Pharmaceuticals Expansion\",\"datePublished\":\"2025-07-25T05:03:02+00:00\",\"dateModified\":\"2025-07-25T05:03:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37935\"},\"wordCount\":235,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37935#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2506.webp\",\"keywords\":[\"Finanical Reports\",\"OTCMKTS: RHHBY\",\"Roche\",\"SWX: ROG\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=37935#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37935\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=37935\",\"name\":\"Roche AG Reports 7% Sales Growth in H1 2025, Driven by Pharmaceuticals Expansion - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37935#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37935#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2506.webp\",\"datePublished\":\"2025-07-25T05:03:02+00:00\",\"dateModified\":\"2025-07-25T05:03:03+00:00\",\"description\":\"Swiss giant Roche AG (SWX: ROG, OTCMKTS: RHHBY) announced its H1 2025 financial results, reporting a 7% year-on-year (YOY) increase in global group sales to CHF 30.94 billion (USD 39 billion) in constant exchange rate terms. The Pharmaceuticals division drove this growth with a 10% expansion to CHF 23.99 billion (USD 30.24 billion), while the Diagnostics division reported flat growth at CHF 6.96 billion (USD 8.77 billion).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37935#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=37935\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37935#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2506.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2506.webp\",\"width\":1080,\"height\":608,\"caption\":\"Roche AG Reports 7% Sales Growth in H1 2025, Driven by Pharmaceuticals Expansion\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37935#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Roche AG Reports 7% Sales Growth in H1 2025, Driven by Pharmaceuticals Expansion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Roche AG Reports 7% Sales Growth in H1 2025, Driven by Pharmaceuticals Expansion - Insight, China&#039;s Pharmaceutical Industry","description":"Swiss giant Roche AG (SWX: ROG, OTCMKTS: RHHBY) announced its H1 2025 financial results, reporting a 7% year-on-year (YOY) increase in global group sales to CHF 30.94 billion (USD 39 billion) in constant exchange rate terms. The Pharmaceuticals division drove this growth with a 10% expansion to CHF 23.99 billion (USD 30.24 billion), while the Diagnostics division reported flat growth at CHF 6.96 billion (USD 8.77 billion).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=37935","og_locale":"en_US","og_type":"article","og_title":"Roche AG Reports 7% Sales Growth in H1 2025, Driven by Pharmaceuticals Expansion","og_description":"Swiss giant Roche AG (SWX: ROG, OTCMKTS: RHHBY) announced its H1 2025 financial results, reporting a 7% year-on-year (YOY) increase in global group sales to CHF 30.94 billion (USD 39 billion) in constant exchange rate terms. The Pharmaceuticals division drove this growth with a 10% expansion to CHF 23.99 billion (USD 30.24 billion), while the Diagnostics division reported flat growth at CHF 6.96 billion (USD 8.77 billion).","og_url":"https:\/\/flcube.com\/?p=37935","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-07-25T05:03:02+00:00","article_modified_time":"2025-07-25T05:03:03+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2506.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=37935#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=37935"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Roche AG Reports 7% Sales Growth in H1 2025, Driven by Pharmaceuticals Expansion","datePublished":"2025-07-25T05:03:02+00:00","dateModified":"2025-07-25T05:03:03+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=37935"},"wordCount":235,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=37935#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2506.webp","keywords":["Finanical Reports","OTCMKTS: RHHBY","Roche","SWX: ROG"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=37935#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=37935","url":"https:\/\/flcube.com\/?p=37935","name":"Roche AG Reports 7% Sales Growth in H1 2025, Driven by Pharmaceuticals Expansion - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=37935#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=37935#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2506.webp","datePublished":"2025-07-25T05:03:02+00:00","dateModified":"2025-07-25T05:03:03+00:00","description":"Swiss giant Roche AG (SWX: ROG, OTCMKTS: RHHBY) announced its H1 2025 financial results, reporting a 7% year-on-year (YOY) increase in global group sales to CHF 30.94 billion (USD 39 billion) in constant exchange rate terms. The Pharmaceuticals division drove this growth with a 10% expansion to CHF 23.99 billion (USD 30.24 billion), while the Diagnostics division reported flat growth at CHF 6.96 billion (USD 8.77 billion).","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=37935#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=37935"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=37935#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2506.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2506.webp","width":1080,"height":608,"caption":"Roche AG Reports 7% Sales Growth in H1 2025, Driven by Pharmaceuticals Expansion"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=37935#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Roche AG Reports 7% Sales Growth in H1 2025, Driven by Pharmaceuticals Expansion"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2506.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/37935","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=37935"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/37935\/revisions"}],"predecessor-version":[{"id":37940,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/37935\/revisions\/37940"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/37936"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=37935"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=37935"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=37935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}